Radiopharmaceuticals for Positron Emission Tomography, Volume 1

Inbunden, Engelska, 2012

Del 1 i serien Wiley Series on Radiochemical Syntheses

1 621 kr

Beställningsvara. Skickas inom 5-8 vardagar. Fri frakt över 249 kr.

Beskrivning

The ultimate reference guide to the synthesis of radiopharmaceuticals The Radiochemical Syntheses series provides scientists and professionals with a comprehensive reference to proven synthetic methods for radiochemical reactions, along with step-by-step guidance on how to replicate these syntheses in the laboratory.Volume 1 in the series focuses on the synthesis and purification of radiopharmaceuticals in clinical use today. It brings together in one complete, self-contained volume a collection of monographs containing a wealth of practical information from across the literature, demonstrating in meticulous detail how to prepare radiopharmaceuticals for positron emission tomography (PET) imaging, especially in tumor studies, cardiology, and neuroscience.Readers have key experimental details culled from the literature at their fingertips, greatly simplifying the process of qualifying a site for the clinical production of new radiopharmaceuticals.

Produktinformation

Utgivningsdatum:2012-03-27
Mått:164 x 241 x 26 mm
Vikt:658 g
Format:Inbunden
Språk:Engelska
Serie:Wiley Series on Radiochemical Syntheses
Antal sidor:368
Förlag:John Wiley & Sons Inc
Medarbetare:MichaelR. Kilbourn
ISBN:9780470588956

Utforska kategorier

Kemi inom Naturvetenskap och teknik
Organisk kemi inom Naturvetenskap och teknik
Medicinsk bildbehandling inom Medicin

Mer om författaren

Peter J. H. Scott is an Assistant Professor in the Department of Radiology at the University of Michigan Medical School. Dr. Scott edited Linker Strategies in Solid-phase Organic Synthesis (also from Wiley) and is the series editor for the Wiley Series on Solid Phase Organic Syntheses. Brian G. Hockley is Radiopharmaceutical Quality Manager at the University of Michigan Medical School, where he works with Michael Kilbourn on radiopharmaceutical research and development. Mr. Hockley has co-authored several articles and a chapter in Linker Strategies in Solid-phase Organic Synthesis (also from Wiley).

Innehållsförteckning

Contributors ixForeword xviiPreface xixAbbreviations xxiPart I Fluorine-18 Labeled Radiopharmaceuticals 11. Synthesis of [18F]-Fluorodeoxyglucose ([18F]FDG) 3Michelle L. Richards and Peter J. H. Scott2. Synthesis of Sodium [18F]Fluoride (Na[18F]F) 15Brian G. Hockley and Peter J. H. Scott3. Radiosynthesis of 3_-Deoxy-3_-[18F]Fluorothymidine ([18F]FLT) 21Hartmuth C. Kolb, Henry C. Padgett, Steve Zigler, Jim Patanella, Fanrong Mu, Umesh B. Gangadharmath, Vani P. Mocharla, Peter J. H. Scott, and Joseph C. Walsh4. Synthesis of [18F]Fluoroazomycin Arabinoside ([18F]FAZA) 31Brian G. Hockley and Peter J. H. Scott5. Synthesis of [18F]Fluoromisonidazole (1-(2-Hydroxy-3-[18F]Fluoropropyl)-2-Nitroimidazole, [18F]FMISO) 41Patrick J. Riss, Valentina Ferrari, Robert Bielik, Roberto Canales-Candela, Rob Smith, and Franklin I. Aigbirhio6. Synthesis of [18F]FPPRGD2 51Shuanglong Liu, Frederick T. Chin, Zhen Cheng, and Xiaoyuan Chen7. Synthesis of [18F]Fluorocholine ([18F]FCH) 61David Kryza8. Clinical Manufacturing of [18F]-16-α-Fluoroestradiol ([18F]FES) 69Piyush Kumar and John R. Mercer9. Synthesis of N-Succinimidyl 4-[18F]Fluorobenzoate ([18F]SFB) 81Xia Shao10. Synthesis of 4-(2_-Methoxyphenyl)-1-[2_-(N-2__Pyridinyl)-p-[18F]Fluorobenzamido]Ethylpiperazine [18F]MPPF 87Marion Alvarez and Didier Le Bars11. Synthesis of [18F]-Fallypride 95Laurent Brichard, Valentina Ferrari, Rob Smith, and Franklin I. Aigbirhio12. Synthesis of [18F]Fluoroethyltyrosine (18F-FET) 103Yi Zhao, Amar Alfteimi, and Maaz Zuhayra13. Synthesis of [18F]Flumazenil ([18F]FZ) 111Ralf Schirrmacher, Alexey Kostikov, Gassan Massaweh, Miriam Kovacevic, Carmen Wängler, and Alexander Thiel14. Synthesis of 6-[18F]Fluorodopamine (6-[18F]FDA) 125Michael A. Channing, John L. Musachio, and Jozef J. Kusmierz15. Synthesis of 2-([18F]Fluoro)-3-[(2S)-2-Azetidinylmethoxy]Pyridine ([18F]2FA) 139Hayden T. Ravert, Daniel P. Holt, and Robert F. Dannals16. Synthesis of [18F]-Substance-P Antagonist-Receptor Quantifier ([18F]SPA-RQ) 155Sofie Celen, Kim Serdons, Tjibbe de Groot, Terence G. Hamill, and Guy BormansPart II Carbon-11 Labeled Radiopharmaceuticals 16717. Synthesis of [11C]Choline Chloride ([11C]CHL) 169Brian G. Hockley, Bradford Henderson, and Xia Shao18. Synthesis of 2-(4-N-[11C]Methylaminophenyl)-6-Hydroxybenzothiazole ([11C]6-OH-BTA-1; [11C]PIB) 177Cécile Philippe, Markus Mitterhauser, and Wolfgang Wadsak19. Synthesis of [11C]-meta-Hydroxyephedrine ([11C]MHED) 191Filippo Lodi, Assunta Carpinelli, Claudio Malizia, and Stefano Boschi20. Synthesis of l-[methyl-11C]Methionine ([11C]MET) 199Amy L. Vāvere and Scott E. Snyder21. Synthesis of (+)-α-[11C]Dihydrotetrabenazine ([11C]DTBZ) 213Michael R. Kilbourn22. Synthesis of [11C]Flumazenil([11C]FMZ) 221Roberto Canales-Candela, Patrick J. Riss, and Franklin I. Aigbirhio23. Synthesis of [11C]Hexadecanoic Acid ([11C]Palmitic Acid) 233Adam C. Runkle, Xia Shao, and Peter J. H. Scott24. Synthesis of O-methyl-11C]Metomidate ([11C]-MTO) 245István Boros and Franklin I. Aigbirhio25. Synthesis of [11C]Carfentanil ([11C]CFN) 257Louis Tluczek and Xia Shao26. Synthesis of [carbonyl-11C]Way-100635 265Jan D. Andersson, Sangram Nag, Raisa N. Krasikova, Victor W. Pike, and Christer Halldin27. Synthesis of [11C]Raclopride 275Xia Shao28. Synthesis of 3-Amino-4-[2-(N-Methyl-N-[11C]Methyl-Amino-Methyl)Phenylsulfanyl]-Benzonitrile ([11C]Dasb) 285Daniela Haeusler, Markus Mitterhauser, and Wolfgang Wadsak29. Synthesis of [11C] Acetate 297Filippo Lodi, Claudio Malizia, and Stefano Boschi30. Synthesis of N-(2-[11C]Methoxybenzyl)-N-(4-Phenoxypyridin-3-yl)Acetamide ([11C]PBR28) 305Qi-Huang Zheng, Min Wang, and Bruce H. MockPart III Other Radiopharmaceuticals 31331. Synthesis of [13N]Ammonia ([13N]NH3) 315Peter J. H. Scott32. Synthesis of [68GA]Gallium Dota-(TYR3)-Octreotide Acetate ([68GA]-Dotatoc) 321Harald Eidherr, Friedrich Girschele, Markus Mitterhauser, and Wolfgang WadsakAppendix 1 Supplier Information 335Index 339